Literature DB >> 11716678

Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells.

A David1, P Kopecková, A Rubinstein, J Kopecek.   

Abstract

N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing pendant saccharide moieties (galactosamine, lactose, and triantennary galactose) were synthesized. The relationship between the content of saccharide moieties and three-dimensional arrangement of galactose residues and their biorecognition and internalization by human hepatocarcinoma HepG2 cells was investigated. The results obtained clearly indicated preferential binding of the trivalent galactose and the lactose-containing copolymers to these cells. The higher the saccharide moieties content in HPMA copolymers, the higher the levels of binding. The biorecognition of the glycosylated HPMA copolymers by HepG2 cells was inhibited by free lactose. The data on the internalization and subcellular trafficking of HPMA copolymer conjugates obtained by confocal fluorescence microscopy correlated well with the flow cytometric analysis of their biorecognition by target cells. Structural features of the glycosides responsible for the specific recognition of the HPMA copolymers have been identified. The results underline the potential of glycosylated HPMA copolymers for delivery of pharmaceutical agents to hepatocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716678     DOI: 10.1021/bc010026v

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  16 in total

1.  N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers.

Authors:  Scott H Medina; Venkatesh Tekumalla; Maxim V Chevliakov; Donna S Shewach; William D Ensminger; Mohamed E H El-Sayed
Journal:  Biomaterials       Date:  2011-03-22       Impact factor: 12.479

2.  Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.

Authors:  Amit Joshi; Arundhati Saraph; Vincent Poon; Jeremy Mogridge; Ravi S Kane
Journal:  Bioconjug Chem       Date:  2006 Sep-Oct       Impact factor: 4.774

3.  Design and development of effective siRNA delivery vehicles.

Authors:  David Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-06       Impact factor: 11.205

4.  Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers.

Authors:  Eric T Sletten; Ravi S Loka; Fei Yu; Hien M Nguyen
Journal:  Biomacromolecules       Date:  2017-09-13       Impact factor: 6.988

Review 5.  Design of smart HPMA copolymer-based nanomedicines.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

6.  The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells.

Authors:  K D Jensen; P Kopecková; J H Bridge; J Kopecek
Journal:  AAPS PharmSci       Date:  2001

7.  The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.

Authors:  Ayelet David; Pavla Kopecková; Jindrich Kopecek; Abraham Rubinstein
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

Review 8.  Biological rationale for the design of polymeric anti-cancer nanomedicines.

Authors:  Yan Zhou; Jindřich Kopeček
Journal:  J Drug Target       Date:  2012-09-26       Impact factor: 5.121

Review 9.  Macromolecular therapeutics.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

10.  Synthesis of Homopolymers and Copolymers Containing an Active Ester of Acrylic Acid by RAFT: Scaffolds for Controlling Polyvalent Ligand Display.

Authors:  Kunal V Gujraty; Mallinamadugu J Yanjarappa; Arundhati Saraph; Amit Joshi; Jeremy Mogridge; Ravi S Kane
Journal:  J Polym Sci A Polym Chem       Date:  2008-09-25       Impact factor: 2.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.